PALI — Palisade Bio, Inc.

PALIPalisade Bio, Inc.

NAS · US · Healthcare · Biotechnology · palisadebio.com

1.975USD+1.28%Mkt Cap: 341.48M USDP/E: 16.38Last update: 2026-05-26

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its l…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap341.48M USD

Enterprise Value216.27M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-16.78M USD

Revenue/Share—

Last Price1.975 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees14

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS6963892046

Valuation

P/E (Trailing)16.38

P/E (Forward)-8.55

PEG—

EV/EBITDA-8.16

EV/Revenue—

P/S—

P/B2.64

EPS (TTM)0.12

EPS (Forward)-0.23

52W Range

0.530062% of range2.860

52W High2.860 USD

52W Low0.5300 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-12.97%

ROA-12.49%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.85M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-2.81%

Net Debt-132.63M USD

Net Debt/EBITDA5.01

Balance Sheet

Debt/Equity0.00

Current Ratio23.71

Quick Ratio23.60

Book Value/Sh0.7610 USD

Cash/Share0.7640 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJul 18, 2019

Splits

Last Split1:15

Split DateApr 8, 2024

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)9.714 USD

Target Range5.000 USD – 25.00 USD

# Analysts7

Ownership

Shares Out.173.58M

Float128.36M

Insiders0.03%

Institutions88.07%

Short Interest

Short Ratio5.2d

Short % Float15.62%

Short % Out.15.60%

Shares Short26.15M

Short (prev mo.)25.77M

Technical

SMA 502.002 (-1.3%)

SMA 2001.672 (+18.1%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)3.81M

Avg Vol (10d)2.76M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—